|1.||Lee, Hae-In: 2 articles (11/2014 - 06/2014)|
|2.||Ham, Ju Ri: 2 articles (11/2014 - 06/2014)|
|3.||Lee, Mi-Kyung: 2 articles (11/2014 - 06/2014)|
|4.||Seo, Kwon-Il: 2 articles (11/2014 - 06/2014)|
|5.||Sim, Mi-Ok: 2 articles (11/2014 - 06/2014)|
|6.||Choi, Jae Sue: 2 articles (09/2014 - 06/2012)|
|7.||Ellis, Elizabeth M: 2 articles (03/2013 - 10/2012)|
|8.||Neychev, Hristo: 2 articles (01/2012 - 01/2007)|
|9.||Stefanova, Tsvetanka: 2 articles (01/2012 - 01/2007)|
|10.||Nunes, Xirley P: 2 articles (02/2010 - 05/2009)|
11/19/2015 - "Photoprotolytic Processes of Umbelliferone and Proposed Function in Resistance to Fungal Infection."
01/01/2012 - "Here we describe the parameters of the protective effect of 7-hydroxycoumarin (7-OHC) in experimental Salmonella enterica Serovar Typhimurium infection in mice. "
02/01/2010 - "Modulation of cytokine production by 7-hydroxycoumarin in vitro and its efficacy against influenza infection in mice."
01/01/2007 - "Here we demonstrate that prophylactic peroral administration of coumarin or 7-hydroxycoumarin (7-OHC) enhances resistance to subsequent lethal Salmonella enterica Serovar Typhimurium infection in mice. "
02/01/2010 - "We previously demonstrated that 7-hydroxycoumarin (7HC) was effective in reducing proinflammatory cytokine production in lipopolysaccharide-exposed macrophage-like P388D1 cells and fever production by suppressing the increase in interleukin (IL)-1alpha production in an influenza virus-intranasal infection model in mice. "
02/01/2010 - "Antinociceptive and anti-inflammatory properties of 7-hydroxycoumarin in experimental animal models: potential therapeutic for the control of inflammatory chronic pain."
01/01/2014 - "In conclusion, umbelliferone possessed strong antinociceptive and anti-inflammatory activities by inhibiting both peripheral and centrally acting pain mediators."
01/01/2014 - "Post-umbelliferone injection evoked significant dose-dependent reduction in noxious stimulation with 33.65% and 58.89% pain attenuation at 5 and 10 mg/kg i.p., respectively, in the initial phase. "
04/25/2011 - "7-Hydroxycoumarin (umbelliferone, 1), the main metabolite of coumarin, has been reported to produce potent antinociceptive effects in animal models of pain. "
07/02/2007 - "Our results showed that Umbelliferone has a protective effect on membrane fatty acid composition of liver and kidney as supported by antioxidant and antihyperlipidemic effects of Umbelliferone reported earlier as evidenced by improved histopathological changes, hepatic and nephritic markers, indicating recovery from the risk of diabetic complications."
06/01/2012 - "capillaris and five key AGE inhibitors, including 4,5-di-Ocaffeoylquinic acid, umbelliferone, esculetin, esculin, and scopoletin, were identified as potential candidates for use as therapeutic or preventive agents for diabetic complications and oxidative stress-related diseases. "
|5.||Human Influenza (Influenza)
|4.||Valproic Acid (Valproate, Semisodium)
|8.||Anticonvulsants (Antiepileptic Drugs)
|2.||Drug Therapy (Chemotherapy)